SecBot SecBot
Insider Buy ·Filed Aug 18, 2026
ML

MLPT

MapLight Therapeutics, Inc.
BULLISH
Impact 7/10
Horizonweeks Processed2mo ago SEC0001900201-26-000005
Insider cluster: 1 insiders, $50.1M total
Actionable Insight ▲ Bullish

This is a powerful bullish signal from a major insider. Traders should monitor for upcoming catalysts such as clinical trial data, partnership announcements, or other corporate developments that may have prompted this large investment. The stock is likely to see upward pressure as the market prices in this vote of confidence.

DirectionBullish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

A 10% owner, Catalyst4, Inc., made a single open-market purchase of 4.4 million shares of MapLight Therapeutics (MLPT) for $50.07 million at $11.38 per share on August 14, 2026. This is a massive conviction buy from a major insider, representing a significant bet on the company's prospects, especially given the context of a second large purchase by the same entity on the same day totaling over $83 million. The sheer size of the investment signals strong confidence from a key shareholder, which is a bullish indicator for the stock.

Key Financial Metrics

Direction
buying
Total Value
$50.1M
Insiders
1

Key Facts

  • 10% owner Catalyst4, Inc. purchased 4,400,000 shares of MLPT on August 14, 2026.
  • Total purchase value was $50,072,000 at an average price of $11.38 per share.
  • This is a single, open-market conviction buy, not a 10b5-1 plan transaction.
  • The same entity also purchased an additional 2,928,686 shares on the same day, bringing the total insider buying for the day to over $83 million.
  • Recent insider activity (30 days) shows 6 buys totaling $98.7 million, indicating a sustained accumulation pattern.

Financial Impact

A 10% owner invested $50.07 million in a single open-market purchase, representing a substantial stake increase.

ownership concentrationinsider confidence

Risk Factors

  • The purchase could be a prelude to a larger strategic move, such as a takeover or going-private transaction, which carries execution risk.
  • Insider buying is not a guarantee of future stock performance; the company's fundamentals and pipeline risks remain.
  • The stock may have already priced in some of this buying activity if it was leaked or anticipated.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001900201-26-000005
2 reports for MLPT
Performance horizon
Filters
Rows
Reports for MLPT — sortable, filterable
TypeNow
Aug 18, 2026
9w ago
Insider Buy
BULLISH ★ 7/10
—awaiting T+20——
Jul 30, 2026
12w ago
Insider Cluster
BULLISH ★ 7/10
—awaiting T+20——
Showing 2 of 2

US Market Status

Market Open — Closes in 3h 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 18, 2026